We believe in helping organizations, patients, CROs, and communities in accelerating hope. If you are interested in learning more about industry-leading technology and analytics, attend one of the upcoming events listed below.
[Webinar] Emerging Biopharma (8-Part Series)
1 PM ET / 10 AM PT
Register now to join Medidata for a special 8-part webinar series featuring third party clinical trial experts. This series will feature content specific to Emerging Biopharma and early-stage Medical Device and Diagnostics sponsors. All webinars in the series will be at 1 PM ET / 10 AM PT and run 30 minutes in length.
The second webinar in the series, Data Management Evolutions (Part 1): CRO Management, will be on November 19th, with Hajime Arnold, Co-Founder, and Executive Director of Data Management at Emanate Life Sciences.
[Webinar] Site Payments: Compare Your Options
November 19th, 2019 | 12 PM ET / 9 AM PT
As clinical trials become more global and intricate, clinical trial financial management complexities continue to escalate. Late and inaccurate payments, fragmented financial data and processes, and unreliable reporting and forecasting continue to unravel the course of your trials. Unfortunately, most Site Payment solutions lack the capabilities to address these challenges.
During this session, we will share:
- What Site Payment capabilities Sponsors and Sites require to maximize their financial health.
- What features from EDC integration, to scalable global payments, to automated tax calculations, have the most critical impact.
- How accurate real time automated forecasting and reporting capabilities, can make or break your trial.
American Society of Hematology Annual Meeting (ASH)
December 7-9 | Orlando, FL
Medidata is proud to be an exhibitor at the 61st ASH (American Society of Hematology) annual meeting and a premier sponsor of the ASH 2019 Foundation Run/Walk. ASH, the second largest Oncology event following ASCO, brings together more than 20,000 hematologists and other healthcare professionals from all 50 states and more than 100 countries in the world. With over 18K clinical trials conducted, comprised of 5.2 million patients, Medidata is uniquely positioned to bring actionable insights to the frontlines of decision-making in dozens of indications, including MM and AML. Visit booth #2461 to learn more about Medidata’s experience and expertise in Hematology and Oncology and join our poster session (publication #3599) on the evening of Monday, Dec. 9 to learn more about the first use of proteomics data to study early indicators of treatment response in Castleman’s disease.
Click here to learn more about our presence at ASH.
Weren't able to meet us at one of our events? Visit our On-Demand Webinars page.